Developmental Disabilities

  • Nancy J. Carpenter
  • Kristin May
  • Benjamin Roa
  • Jack Tarleton


Although the classic childhood phenotypes of many developmental disorders have been established for some time, only in the past decade have the genetic etiologies of some of these disorders been identified. Investigations of the molecular basis of these conditions have resulted in the identification of new genes, leading to insights into the function of new proteins and biochemical pathways. In addition, genetic mechanisms previously unknown in humans, such as genomic imprinting, uniparental disomy, expansion of trinucleotide repeats, and facilitation of deletions and duplications by low-copy repeats, were recognized as the causes of some of these conditions.


Williams Syndrome Rett Syndrome Angelman Syndrome Full Mutation Uniparental Disomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66:817–822.PubMedCrossRefGoogle Scholar
  2. 2.
    Saul RA, Tarleton J, Fragile X syndrome. In: GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Seattle: University of Washington; 1997–2003.Google Scholar
  3. 3.
    Eichler EE, Richards S, Gibbs RA, et al. Fine structure of the human FMR1 gene. Hum Mol Genet. 1993;2:1147–1153.PubMedCrossRefGoogle Scholar
  4. 4.
    Rousseau F, Heitz D, Biancalana V, et al. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med. 1991;325:1673–1681.PubMedCrossRefGoogle Scholar
  5. 5.
    Fu YH, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67:1047–1058.PubMedCrossRefGoogle Scholar
  6. 6.
    Tassone F, hagerman RJ, Ikle DN, et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet. 1999;84:250–261.PubMedCrossRefGoogle Scholar
  7. 7.
    Engel E. A new genetic concept: uniparental disomy and its potential effect. Am J Med Genet. 1980;6:137–143.PubMedCrossRefGoogle Scholar
  8. 8.
    Engel E, Antonarakis SE. Genomic Imprinting and Uniparental Disomy in Medicine: Clinical and Molecular Aspects. New York: Wiley-Liss; 2002.Google Scholar
  9. 9.
    Spence JE, Perciaccante RG, Greig GM, et al. Uniparental disomy as a mechanism for human genetic disease. Am J Hum Genet. 1988;42:217–226.PubMedGoogle Scholar
  10. 10.
    Sapienza C, Hall JG, Scriver CR, Beaudet AR, Sly WS, et al. Genome imprinting in human disease. In: Scriver CR, et al., eds. The Metabolic and Molecular Basis of Inherited Disease, 8th ed. New York: McGraw-Hill; 2001.Google Scholar
  11. 11.
    Gallagher RC, Pils, B, Albalwi M, et al. Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet. 2002;71:669–678.PubMedCrossRefGoogle Scholar
  12. 12.
    Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15:70–73.PubMedCrossRefGoogle Scholar
  13. 13.
    Cassidy SB, Schwartz S. Prader-Willi syndrome. In: GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Seattle: University of Washington; 1997–2003.Google Scholar
  14. 14.
    Williams CA, Lossie AC, Driscoll DJ. Angelman syndrome. In: GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Seattle: University of Washington; 1997–2003.Google Scholar
  15. 15.
    Malzac P, Webber H, Moncla A, et al. Mutation analysis of UBE3A in Angelman syndrome patients. Am J Hum Genet. 1998;62:1353–1360.PubMedCrossRefGoogle Scholar
  16. 16.
    Beuten J, Sutcliff JS, Casey BM, et al. Detection of imprinting mutations in Angelman syndrome using a probe for exon α of SNRPN [letter]. Am J Med Genet. 1996;63:414–415.PubMedCrossRefGoogle Scholar
  17. 17.
    Kubota T, Das S, Christian SL, et al. Methylation-specific PCR simplifies imprinting analysis [letter]. Nat Genet 1997;16:16–17.PubMedGoogle Scholar
  18. 18.
    American Society of Human Genetics/American College of Medical Genetics Test and Technology Transfer Committee. Diagnostic testing for Prader-Willi and Angelman syndromes: report of the ASHG/ACMG Test and Technology Transfer Committee. Am J Hum Genet. 1996;58:1085–1088.Google Scholar
  19. 19.
    Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol. 1983;14:471–479.PubMedCrossRefGoogle Scholar
  20. 20.
    Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185–188.PubMedCrossRefGoogle Scholar
  21. 21.
    Shahbazian MD, Zoghbi HY. Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet. 2002;71:1259–1272.PubMedCrossRefGoogle Scholar
  22. 22.
    Fang P, Jin W, Glaze DG, Percy A, Zoghbi HY, Roa BB. MECP2 gene deletions account for ∼10% of Rett syndrome cases. The American Society of Human Genetics. 2004;476:2652.Google Scholar
  23. 23.
    Mnatzakanian GN, Lohi H, Munteanu I, et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet. 2004;36:339–341.PubMedCrossRefGoogle Scholar
  24. 24.
    Buyse IM, Roa BB. Denaturing high-performance liquid chromatography and sequence analysis for MECP2 mutations in Rett syndrome. In: Potter NT, ed. Methods in Molecular Biology: Neurogenetics Methods and Protocols. Vol. 217. Totowa, NJ: Humana Press; 2002:119–130.Google Scholar
  25. 25.
    ACMG Laboratory Practice Committee Working Group. ACMG recommendations for standards for interpretation of sequence variations. Genet Med. 2000;2:302–330.Google Scholar
  26. 26.
    Morris CA. Williams Syndrome. In: Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes, 2nd ed. New York: Wiley-Liss; 2005:655–665.Google Scholar
  27. 27.
    Osborne LR, Li M, Pober B, et al. A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet. 2001;29:321–325.PubMedCrossRefGoogle Scholar
  28. 28.
    Li DY, Faury G, Taylor DG, et al. Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest. 1998;102:1783–1787.PubMedCrossRefGoogle Scholar
  29. 29.
    Tassabehji M, Metcalfe K, Karmiloff-Smith A, et al. Williams syndrome: use of chromosomal microdeletions as a tool to dissect cognitive and physical phenotypes. Am J Hum Genet. 1999;64:118–125.PubMedCrossRefGoogle Scholar
  30. 30.
    Knight SJL, Flint J. Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis. J Med Genet. 2000;37:401–409.PubMedCrossRefGoogle Scholar
  31. 31.
    Mefford HC, Trask BJ. The complex structure and dynamic evolution of human subtelomeres. Nat Rev Genet. 2002;3:91–102.PubMedCrossRefGoogle Scholar
  32. 32.
    Biesecker LG. The end of the beginning of chromosome ends. Am J Med Genet. 2002;107:263–266.PubMedCrossRefGoogle Scholar
  33. 33.
    Knight SJL, Lese CM, Precht KS, et al. An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet. 2000;67:320–332.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Nancy J. Carpenter
    • 1
  • Kristin May
    • 2
  • Benjamin Roa
    • 3
  • Jack Tarleton
    • 4
  1. 1.Center for Genetic TestingSaint Francis Health SystemTulsaUSA
  2. 2.Genetic Diagnostic LaboratoryTC Thompson Children’s HospitalChattanoogaUSA
  3. 3.Department of Molecular and Human GeneticsBaylor College of MedicineHoustonUSA
  4. 4.Fullerton Genetics Center LaboratoryMission HospitalsAshevilleUSA

Personalised recommendations